Every story in this section, newest first — page 271 of 373.
Vision Marine Technologies (NASDAQ:VMAR) disclosed significant growth within its direct-to-consumer rental division on Monday, reporting that its Portside Ventura, California operations saw a 167% year-over-year increase in excursion volume.
EchoStar (NASDAQ:SATS) disclosed a massive $14.50 billion net loss for the full year 2025, a figure primarily fueled by a series of aggressive accounting adjustments to its balance sheet.
Hudbay Minerals (NYSE:HBM) and Arizona Sonoran Copper Company (ASCU) announced a definitive merger agreement on Monday, marking the creation of a massive new "copper district" in southern Arizona.
TRX Gold (NYSE:TRX) delivered a landmark second quarter for fiscal 2026, reporting record production and a transformed capital structure that positions the company for aggressive growth at its Buckreef Gold Project.
Zymeworks (NASDAQ:ZYME) reported a significant narrowing of its annual losses and a double-digit jump in revenue on Monday, driven by the continued maturation of its oncology-focused licensing portfolio.
RadNet (NASDAQ:RDNT) reported record fourth-quarter and full-year 2025 results today, underscoring the success of its dual-track strategy to dominate both physical outpatient imaging and the burgeoning clinical AI market.
Belite Bio (NASDAQ:BLTE), a clinical-stage biopharmaceutical company focused on developing therapies for degenerative retinal diseases, today announced positive topline results from its pivotal Phase 3 DRAGON trial evaluating tinlarebant, an oral retinol binding protein 4 (RBP4) antagonist, for the treatment of adolescent Stargardt disease.
RadNet (NASDAQ:RDNT) announced a definitive agreement on Monday to acquire Gleamer SAS, a Paris-based pioneer in radiology artificial intelligence, for a total consideration of up to €230 million.
Yatsen Holding (NYSE:YSG) reported fourth-quarter and full-year 2025 results on Monday, marking a definitive turning point in its multi-year transition from a mass-market cosmetics player to a premium, skincare-led beauty group.
Global equity markets retreated sharply on Monday as a coordinated U.S. and Israeli military strike against Iran upended geopolitical stability, sending shockwaves through the travel and discretionary sectors.
Oil prices surged in early Monday trading as the military conflict between the United States, Israel, and Iran moved into a high-intensity phase, threatening the stability of the world's most critical energy transit routes.
Gold prices advanced for a fourth consecutive day on Monday, reaching a four-week high as a dramatic escalation of war in the Middle East sent investors scrambling for protection.
Berkshire Hathaway (NYSE:BRK-B) reported fourth-quarter net income of $19.2 billion, or $8.90 per share, as the Omaha-based conglomerate navigated a challenging transition period marked by insurance headwinds and significant investment writedowns.
Kosmos Energy (NYSE:KOS) reported a fourth-quarter net loss of $377 million, or $0.79 per share, as the company prioritized balance sheet discipline and portfolio optimization at the close of 2025.
Prime Minister Anthony Albanese has declared Australia's support for the United States' military intervention in Iran, following a massive joint US-Israeli operation on Feb. 28.
Via Transportation (NYSE:VIA) posted fourth-quarter revenue of $119 million on Friday, a 30% increase that capped its first full year as a publicly traded company.
Gogo (NASDAQ:GOGO) delivered a transformative set of 2025 results on Friday, with annual revenue more than doubling to $910.5 million.
TXNM Energy (NYSE:TXNM), the holding company for Public Service Company of New Mexico (PNM) and Texas-New Mexico Power (TNMP), on Friday reported GAAP diluted earnings per share of $1.48 for the full year 2025, down from $2.67 in 2024.
Merck (NYSE:MRK) unveiled groundbreaking final results from the Phase 3 KEYNOTE-B96 trial today at the ESGO 2026 Congress, demonstrating that a Keytruda-based regimen can extend the lives of patients facing one of the most aggressive forms of ovarian cancer.
ALX Oncology Holdings (NASDAQ:ALXO) reported fourth-quarter and full-year 2025 results on Friday, highlighting a fundamental shift toward a biomarker-driven strategy that could redefine patient selection for its immuno-oncology pipeline.
JinkoSolar Holding (NYSE:JKS) disclosed preliminary full-year 2025 results for its majority-owned subsidiary, Jiangxi Jinko, today, revealing the deep financial toll of the ongoing solar industry "price war."
Sunstone Hotel Investors (NYSE:SHO) capped fiscal 2025 with a stronger-than-expected fourth quarter, reporting net income of $7.2 million—a significant jump from the $0.8 million recorded in the same period last year.
Alpha Metallurgical Resources (NYSE:AMR) reported definitive fourth-quarter 2025 results on Friday, confirming a net loss of $17.3 million, or $1.34 per diluted share.
Global Partners (NYSE:GLP) reported a steady finish to fiscal 2025 on Friday, with fourth-quarter net income rising to $25.1 million, or $0.54 per diluted unit, compared to $23.9 million a year earlier.
